Organization of and Allocation of Resources to Biomedical Research and Development.

by Joseph P. Newhouse

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback25 pages $20.00 $16.00 20% Web Discount

Analytically, research and development are distinguished as follows: (1) Development involves improvement of a technology whose dimensions are known; in research, unknown. (2) Development generally involves the ultimate production of a marketable product; research does not. Development generally takes place in and is financed by the private sector; research, by the public sector. The institutional arrangements in the private sector may not lead to a sufficient amount of development in total or a proper mix of projects, but satisfactory remedies are hard to find. Also to what extent is the rate of development a function of the rate of spending? RAND's methodology has determined this for jet engines and it may be applicable to biomedical development. Since research is publicly financed on a cost-reimbursement basis, methods are necessary to ensure efficiency, but no easy solutions exist. Finally, the links between R&D, widely presumed to exist, are only beginning to be estimated empirically. 25 pp. Bibliog.

This report is part of the RAND Corporation paper series. The paper was a product of the RAND Corporation from 1948 to 2003 that captured speeches, memorials, and derivative research, usually prepared on authors' own time and meant to be the scholarly or scientific contribution of individual authors to their professional fields. Papers were less formal than reports and did not require rigorous peer review.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.